Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CVRX - CVRx Inc


IEX Last Trade
9.85
-0.010   -0.102%

Share volume: 148,035
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$9.86
-0.01
-0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
27%
Profitability 25%
Dept financing 14%
Liquidity 75%
Performance 21%
Company vs Stock growth
vs
Performance
5 Days
12.94%
1 Month
24.42%
3 Months
43.31%
6 Months
-50.65%
1 Year
-43.91%
2 Year
31.99%
Key data
Stock price
$9.85
P/E Ratio 
-3.95
DAY RANGE
N/A - N/A
EPS 
-$2.58
52 WEEK RANGE
$6.40 - $33.14
52 WEEK CHANGE
-$0.43
MARKET CAP 
214.807 M
YIELD 
N/A
SHARES OUTSTANDING 
21.786 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
1.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$354,107
AVERAGE 30 VOLUME 
$337,341
Company detail
CEO:
Region: US
Website: cvrx.com
Employees: 184
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

cvrx is a private company located in minneapolis, minnesota. the company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. the barostim neo™ uses cvrx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. the barostim neo can be adjusted to meet each patient’s individual therapy needs.

Recent news